Recent Progress toward Engineering HIV-1-Specific Neutralizing Monoclonal Antibodies
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent Progress toward Engineering HIV-1-Specific Neutralizing Monoclonal Antibodies
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2016-09-30
DOI
10.3389/fimmu.2016.00391
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- VRC01 antibody protects against vaginal and rectal transmission of human immunodeficiency virus 1 in hu-BLT mice
- (2016) Ming Sun et al. ARCHIVES OF VIROLOGY
- Engineered Bispecific Antibodies with Exquisite HIV-1-Neutralizing Activity
- (2016) Yaoxing Huang et al. CELL
- Key gp120 Glycans Pose Roadblocks to the Rapid Development of VRC01-Class Antibodies in an HIV-1-Infected Chinese Donor
- (2016) Leopold Kong et al. IMMUNITY
- Improving the CH1-CK heterodimerization and pharmacokinetics of 4Dm2m, a novel potent CD4-antibody fusion protein against HIV-1
- (2016) Weizao Chen et al. mAbs
- Sustained Delivery of a Broadly Neutralizing Antibody in Nonhuman Primates Confers Long-Term Protection against Simian/Human Immunodeficiency Virus Infection
- (2015) Kevin O. Saunders et al. JOURNAL OF VIROLOGY
- Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
- (2015) Marina Caskey et al. NATURE
- AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges
- (2015) Matthew R. Gardner et al. NATURE
- Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection
- (2015) Rebecca M. Lynch et al. Science Translational Medicine
- Structural Insights on the Role of Antibodies in HIV-1 Vaccine and Therapy
- (2014) Anthony P. West et al. CELL
- Rational Design and Characterization of the Novel, Broad and Potent Bispecific HIV-1 Neutralizing Antibody iMabm36
- (2014) Ming Sun et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmission
- (2014) Alejandro B Balazs et al. NATURE MEDICINE
- Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex
- (2014) Devin Sok et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia
- (2013) Masashi Shingai et al. NATURE
- Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys
- (2013) Dan H. Barouch et al. NATURE
- Strategic addition of an N-linked glycan to a monoclonal antibody improves its HIV-1–neutralizing activity
- (2013) Ruijiang Song et al. NATURE BIOTECHNOLOGY
- Bispecific antibodies directed to CD4 domain 2 and HIV envelope exhibit exceptional breadth and picomolar potency against HIV-1
- (2013) C. S. Pace et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice
- (2013) J. A. Horwitz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange
- (2013) A. F. Labrijn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibitory effect of HIV-specific neutralizing IgA on mucosal transmission of HIV in humanized mice
- (2012) E. M. Hur et al. BLOOD
- Progress in overcoming the chain association issue in bispecific heterodimeric IgG antibodies
- (2012) Christian Klein et al. mAbs
- Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
- (2012) Jinghe Huang et al. NATURE
- HIV therapy by a combination of broadly neutralizing antibodies in humanized mice
- (2012) Florian Klein et al. NATURE
- Lessons learned from HIV-1 vaccine trials: new priorities and directions
- (2012) Andrew J McMichael et al. NATURE IMMUNOLOGY
- Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo
- (2012) B. Moldt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4+ T Cell Decline and High Viral Load during Acute Infection
- (2011) E. S. Gray et al. JOURNAL OF VIROLOGY
- Engineering the variable region of therapeutic IgG antibodies
- (2011) Tomoyuki Igawa et al. mAbs
- Precisely tuned antibodies nab HIV
- (2011) Paul R. Clapham et al. NATURE
- Broad neutralization coverage of HIV by multiple highly potent antibodies
- (2011) Laura M. Walker et al. NATURE
- Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies
- (2011) W. Schaefer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Increasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design
- (2011) R. Diskin et al. SCIENCE
- Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
- (2011) J. F. Scheid et al. SCIENCE
- A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
- (2011) R. Pejchal et al. SCIENCE
- Chikungunya Virus Neutralization Antigens and Direct Cell-to-Cell Transmission Are Revealed by Human Antibody-Escape Mutants
- (2011) Chia Yin Lee et al. PLoS Pathogens
- Antibody Epitope Exposure and Neutralization of HIV-1
- (2010) Ralph A. Pantophlet CURRENT PHARMACEUTICAL DESIGN
- Crystal Structure of PG16 and Chimeric Dissection with Somatically Related PG9: Structure-Function Analysis of Two Quaternary-Specific Antibodies That Effectively Neutralize HIV-1
- (2010) M. Pancera et al. JOURNAL OF VIROLOGY
- Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization
- (2010) Tomoyuki Igawa et al. NATURE BIOTECHNOLOGY
- Structure and function of broadly reactive antibody PG16 reveal an H3 subdomain that mediates potent neutralization of HIV-1
- (2010) R. Pejchal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structure-based engineering of a monoclonal antibody for improved solubility
- (2010) S.-J. Wu et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Improving the solubility of anti-LINGO-1 monoclonal antibody Li33 by isotype switching and targeted mutagenesis
- (2010) R. Blake Pepinsky et al. PROTEIN SCIENCE
- Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
- (2010) T. Zhou et al. SCIENCE
- Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
- (2010) X. Wu et al. SCIENCE
- Structure of the HIV-1 gp41 Membrane-Proximal Ectodomain Region in a Putative Prefusion Conformation†,‡
- (2009) Jie Liu et al. BIOCHEMISTRY
- Novel Targets for Antiretroviral Therapy
- (2009) Birgitt Dau et al. DRUGS
- Evaluation of CD4-CD4i Antibody Architectures Yields Potent, Broadly Cross-Reactive Anti-Human Immunodeficiency Virus Reagents
- (2009) A. P. West et al. JOURNAL OF VIROLOGY
- Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys
- (2009) Philip R Johnson et al. NATURE MEDICINE
- Examination of the contributions of size and avidity to the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10
- (2009) J. S. Klein et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
- (2009) L. M. Walker et al. SCIENCE
- Characterization of a trimeric MPER containing HIV-1 gp41 antigen
- (2009) Andreas Hinz et al. VIROLOGY
- CCR5 monoclonal antibodies for HIV-1 therapy
- (2009) William C Olson et al. Current Opinion in HIV and AIDS
- Limited Neutralizing Antibody Specificities Drive Neutralization Escape in Early HIV-1 Subtype C Infection
- (2009) Penny L. Moore et al. PLoS Pathogens
- Safety, Pharmacokinetics, and Antiretroviral Activity of Multiple Doses of Ibalizumab (formerly TNX-355), an Anti-CD4 Monoclonal Antibody, in Human Immunodeficiency Virus Type 1-Infected Adults
- (2008) J. M. Jacobson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Human domain antibodies to conserved sterically restricted regions on gp120 as exceptionally potent cross-reactive HIV-1 neutralizers
- (2008) W. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started